BTMD.NASDAQBiote CORP

Form 4: Biote Corp. Director Dana Lynn Jacoby Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Dana Lynn Jacoby reports acquisition and disposal of Biote Corp. Class A Common Stock and Deferred Settlement RSUs.

Summary

  • On May 13, 2025, Dana Lynn Jacoby, a director of Biote Corp., reported transactions involving Class A Common Stock and Deferred Settlement RSUs.
  • Jacoby acquired 12,994 shares of Class A Common Stock through the vesting of Deferred Settlement RSUs and disposed of the same amount.
  • Following the transaction, Jacoby directly owns 63,964 shares of Class A Common Stock.
  • Jacoby also acquired 21,587 Deferred Settlement RSUs, which are fully vested upon grant but settlement is deferred until separation from service.
  • Additionally, Jacoby acquired a stock option to buy 104,547 shares of Class A Common Stock at a price of $3.91, vesting on the earlier of May 13, 2026, or the day prior to the Issuer's 2026 Annual Meeting of Stockholders.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation. There is no indication of significant positive or negative sentiment.

Positives

  • The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

Settlement of the Deferred Settlement RSUs will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service. The stock options vest on the earlier of May 13, 2026 or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to continuous service.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment about the company's prospects.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely to be minimal.

Key Dates

DateDescription
05/13/2025Date of transaction for Class A Common Stock and Deferred Settlement RSUs.
05/13/2026Earliest vesting date for the stock option award.
05/12/2035Expiration date for the stock option award.

Keywords

Form 4, Biote Corp., BTMD, Dana Lynn Jacoby, Director, Stock, RSU, Stock Option, Beneficial Ownership, Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.